Prosthetic joint infection due to rapidly growing mycobacteria: Report of 8 cases and review of the literature

Clinical Infectious Diseases

Volumn 45, Issue 6, 2007, Pages 687-694

  Eid, Albert J ^a   Berbari, Elie F ^a   Sia, Irene G ^a   Wengenack, Nancy L ^a   Osmon, Douglas R ^a   Razonable, Raymund R ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZITHROMYCIN; CILASTATIN PLUS IMIPENEM; CLARITHROMYCIN; COTRIMOXAZOLE; GENTAMICIN; MOXIFLOXACIN; TOBRAMYCIN; VANCOMYCIN;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTHRALGIA; ARTHROPLASTY; BACTERIAL GROWTH; BACTERIUM ISOLATION; CLINICAL ARTICLE; CLINICAL PRACTICE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; HUMAN; IMPLANTATION; JOINT PROSTHESIS; JOINT SWELLING; MALE; MEDICAL RECORD; MYCOBACTERIUM; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM SMEGMATIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTHESIS INFECTION; REIMPLANTATION; RELAPSE; RETROSPECTIVE STUDY; REVIEW; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; JOINT PROSTHESIS; MALE; MIDDLE AGED; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; PROSTHESIS-RELATED INFECTIONS;

EID: 34548480678     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520982     Document Type: Review

References (28)

1. Kurtz S, Mowat F, Ong K, Chan N, Lau E, Halpern M. Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002. J Bone Joint Surg Am 2005; 87:1487-97.
2. Barnes S, Salemi C, Fithian D, et al. An enhanced benchmark for prosthetic joint replacement infection rates. Am J Infect Control 2006; 34:669-72.
3. Salemi C, Anderson D, Flores D. American Society of Anesthesiology scoring discrepancies affecting the National Nosocomial Infection Surveillance System: surgical-site-infection risk index rates. Infect Control Hosp Epidemiol 1997; 18:246-7.
4. Sia IG, Berbari EF, Karchmer AW. Prosthetic joint infections. Infect Dis Clin North Am 2005; 19:885-914.
5. Berbari EF, Hanssen AD, Duffy MC, Steckelberg JM, Osmon DR. Prosthetic joint infection due to Mycobacterium tuberculosis: a case series and review of the literature. Am J Orthop 1998; 27:219-27.
6. Wolinsky E. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 1979; 119:107-59.
7. Wallace RJ Jr, Swenson JM, Silcox VA, Good RC, Tschen JA, Stone MS. Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis 1983; 5:657-79.
8. Wallace RJ Jr, Brown BA, Onyi GO. Skin, soft tissue, and bone infections due to Mycobacterium chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis 1992; 166:405-12.
9. Hoffman PC, Fraser DW, Robicsek F, O'Bar PR, Mauney CU. Two outbreaks of sternal wound infection due to organisms of the Mycobacterium fortuitum complex. J Infect Dis 1981; 143:533-42.
10. Kuritsky JN, Bullen MG, Broome CV, Silcox VA, Good RC, Wallace RJ Jr. Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex. Ann Intern Med 1983; 98:938-9.
11. Berry DJ, Kessler M, Morrey BF. Maintaining a hip registry for 25 years: Mayo Clinic experience. Clin Orthop Relat Res 1997; 344:61-8.
12. Veronique Vincent V, Brown-Elliot BA, Jost KC Jr, Wallace RJ Jr. Phenotypic and genotypic identification. In: Murray PR, ed. Manual of clinical microbiology. 8th ed., vol. 1. Washington, DC: ASM Press, 2003:562-74.
13. Hall L, Doerr KA, Wohlfiel SL, Roberts GD. Evaluation of the MicroSeq system for identification of mycobacteria by 16S ribosomal DNA sequencing and its integration into a routine clinical mycobacteriology laboratory. J Clin Microbiol 2003;41:1447-53.
14. Clinical and Laboratory Standards Institute. Susceptibility testing of mycobacteriae, nocardiae, and other aerobic actinomycetes; approved standards. CLSI document M24-A. Wayne, PA: Clinical and Laboratory Standards Institute, 2003.
15. Bergogne-Berezin E, Nouhouayi A, Pierre J. Suppuration sur prothese de hance a Mycobacterium chelonei. Rev Fr Mal Resp 1976;4:211-2.
16. Badelon O, David H, Meyer L, Radault A, Zucman J. Mycobacterium fortuitum infection after total hip prosthesis: a report of 3 cases [in French]. Rev Chir Orthop Reparatrice Appar Mot 1979; 65:39-43.
17. Booth JE, Jacobson JA, Kurrus TA, Edwards TW. Infection of prosthetic arthroplasty by Mycobacterium fortuitum: two case reports. J Bone Joint Surg Am 1979; 61:300-2.
18. Delrieu F, Slaoui O, Evrard J, Amor B, Postel M, Kerboull M. Mycobacterial infection of the hip following total prosthesis: study of 6 cases [in French]. Rev Rhum Mal Osteoartic 1986; 53:113-8.
19. Heathcock R, Dave J, Yates MD. Mycobacterium chelonae hip infection. J Infect 1994; 28:104-5.
20. Herold RC, Lotke PA, MacGregor RR. Prosthetic joint infections secondary to rapidly growing Mycobacterium fortuitum. Clin Orthop Relat Res 1987; 216:183-6.
21. Horadam VW, Smilack JD, Smith EC. Mycobacterium fortuitum infection after total hip replacement. South Med J 1982; 75:244-6.
22. Pring M, Eckhoff DG. Mycobacterium chelonae infection following a total knee arthroplasty. J Arthroplasty 1996; 11:115-6.
23. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175:367-416.
24. Meyers H, Brown-Elliott BA, Moore D, et al. An outbreak of Mycobacterium chelonae infection following liposuction. Clin Infect Dis 2002; 34:1500-7.
25. Chen JM, German GJ, Alexander DC, Ren H, Tan T, Liu J. Roles of Lsr2 in colony morphology and biofilm formation of Mycobacterium smegmatis. J Bacteriol 2006; 188:633-41.
26. Howard ST, Rhoades E, Recht J, et al. Spontaneous reversion of Mycobacterium abscessus from a smooth to a rough morphotype is associated with reduced expression of glycopeptidolipid and reacquisition of an invasive phenotype. Microbiology 2006; 152:1581-90.
27. Teng R, Dick T. Isoniazid resistance of exponentially growing Mycobacterium smegmatis biofilm culture. FEMS Microbiol Lett 2003; 227:171-4.
28. Bardouniotis E, Ceri H, Olson ME. Biofilm formation and biocide susceptibility testing of Mycobacterium fortuitum and Mycobacterium marinum. Curr Microbiol 2003; 46:28-32.